Fig. 1.
![Fig. 1. Actuarial survival from relapse according to prognostic features. / (A) Donor type (SIB, HLA-identical sibling; VUD, volunteer unrelated donor); (B) interval from diagnosis to transplant; (C) disease phase at transplant (CP, chronic phase); (D) time to relapse; (E) disease stage at relapse (CYT, cytogenetic relapse; HCP, hematologic relapse in chronic phase; HAP, hematologic relapse in advanced phase [ie, accelerated phase or blastic phase]).](https://ash.silverchair-cdn.com/ash/content_public/journal/blood/95/11/10.1182_blood.v95.11.3328/6/bloo01128001x.jpeg?Expires=1724247157&Signature=L0Ff~QBKd6PojXxwdI7WH8rRO3Jly2-8OoKgl7qn4rLHCo5fzDhHlPuBNYZ1pL6R8ktHpxQaKtP5SWdSrwgd1bHP1gJ204IJOJ1HWh9E60yiVbMRrVpuQfYwS8zYh~rumkEHkjYw1mPANkGGfjYBi9wfsJ2sLvdbWQdJy2~O3KMWuZE0AsQ2wlJTtKGXjihlZ7-gH1cmY6rKYD-nKvHIfxjf6kh3I3lyOrrxWqYRUNRroAedw0YSB5kAtISiKmrsPmSspyMhzFsfcGFwMiXXecY~t2QT6h~SbHLEUjsksScZ2QIr4XN1qBMhnI7MKKtffqIMWl5dDTGc2hP3gq8-2g__&Key-Pair-Id=APKAIE5G5CRDK6RD3PGA)
Actuarial survival from relapse according to prognostic features.
(A) Donor type (SIB, HLA-identical sibling; VUD, volunteer unrelated donor); (B) interval from diagnosis to transplant; (C) disease phase at transplant (CP, chronic phase); (D) time to relapse; (E) disease stage at relapse (CYT, cytogenetic relapse; HCP, hematologic relapse in chronic phase; HAP, hematologic relapse in advanced phase [ie, accelerated phase or blastic phase]).
